Cargando…

Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon

BACKGROUND: Annual community-directed treatment with ivermectin (CDTI) have been carried out since 1999 in the Lekie division (central region of Cameroon where most cases of Loa-related post ivermectin severe adverse events were reported) as part of the joined activities of the African Programme for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kouam, Marc K, Tchatchueng-Mbougua, Jules B, Demanou, Maurice, Boussinesq, Michel, Pion, Sébastien DS, Kamgno, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849770/ https://www.ncbi.nlm.nih.gov/pubmed/24289520 http://dx.doi.org/10.1186/1756-3305-6-283

Ejemplares similares

Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas
por: Niamsi-Emalio, Yannick, et al.
Publicado: (2021)

Effect of a Single Standard Dose (150–200 μg/kg) of Ivermectin on Loa loa Microfilaremia: Systematic Review and Meta-analysis
por: Pion, Sébastien D, et al.
Publicado: (2019)

Projected Number of People With Onchocerciasis–Loiasis Coinfection in Africa, 1995 to 2025
por: Vinkeles Melchers, Natalie V S, et al.
Publicado: (2020)

Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually
por: Campillo, Jérémy T., et al.
Publicado: (2020)

Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness
por: Walker, Martin, et al.
Publicado: (2017)

Dynamics of Onchocerca volvulus Microfilarial Densities after Ivermectin Treatment in an Ivermectin-naïve and a Multiply Treated Population from Cameroon
por: Pion, Sébastien D. S., et al.
Publicado: (2013)

Community-based door to door census of suspected people living with epilepsy: empowering community drug distributors to improve the provision of care to rural communities in Cameroon
por: Kamgno, Joseph, et al.
Publicado: (2020)

Reproductive Status of Onchocerca volvulus after Ivermectin Treatment in an Ivermectin-Naïve and a Frequently Treated Population from Cameroon
por: Nana-Djeunga, Hugues C., et al.
Publicado: (2014)

Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa
por: Wanji, Samuel, et al.
Publicado: (2018)

Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon
por: Wanji, Samuel, et al.
Publicado: (2009)

Fifteen Years of Annual Mass Treatment of Onchocerciasis with Ivermectin Have Not Interrupted Transmission in the West Region of Cameroon
por: Katabarwa, Moses N., et al.
Publicado: (2013)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
por: Boullé, Charlotte, et al.
Publicado: (2019)

Knowledge/perception and attitude/practices of populations of two first-line communities of the Centre Region of Cameroon regarding onchocerciasis and black fly nuisance and bio-ecology
por: Domche, André, et al.
Publicado: (2021)

Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment
por: Wanji, Samuel, et al.
Publicado: (2015)

Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon
por: Wanji, Samuel, et al.
Publicado: (2005)

Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon
por: Boussinesq, Michel, et al.
Publicado: (2003)

Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis
por: Haselow, Nancy J, et al.
Publicado: (2003)

Atypical Clinical Manifestations of Loiasis and Their Relevance for Endemic Populations
por: Buell, Kevin G, et al.
Publicado: (2019)

Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon
por: Kamga, Guy-Roger, et al.
Publicado: (2018)

Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment
por: Bourguinat, Catherine, et al.
Publicado: (2007)

Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control
por: Thomson, Madeleine C, et al.
Publicado: (2004)

Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
por: Brieger, William R, et al.
Publicado: (2011)

Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon
por: Nditanchou, Rogers, et al.
Publicado: (2023)

The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon
por: Abong, Raphael Awah, et al.
Publicado: (2021)

A Second Population-Based Cohort Study in Cameroon Confirms the Temporal Relationship Between Onchocerciasis and Epilepsy
por: Chesnais, Cédric B, et al.
Publicado: (2020)

“Test and not treat” for onchocerciasis control in a Loa loa endemic area
por: Kamgno, Joseph, et al.
Publicado: (2017)

Case-control Studies on the Relationship between Onchocerciasis and Epilepsy: Systematic Review and Meta-analysis
por: Kaiser, Christoph, et al.
Publicado: (2013)

Performance of two serodiagnostic tests for loiasis in a Non-Endemic area
por: Gobbi, Federico, et al.
Publicado: (2020)

Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
por: Campillo, Jérémy T, et al.
Publicado: (2021)

Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination
por: Nana-Djeunga, Hugues C., et al.
Publicado: (2015)

Co-endemicity of Loiasis and Onchocerciasis in Rain Forest Communities in Southwestern Nigeria
por: Ojurongbe, Olusola, et al.
Publicado: (2015)

Development and validation of small animal models for onchocerciasis and loiasis microfilaricide discovery
por: Ayiseh, Rene Bilingwe, et al.
Publicado: (2023)

Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
por: Forrer, Armelle, et al.
Publicado: (2021)

Pulmonary Loiasis and HIV Coinfection in Rural Cameroon
por: Cambanis, Alexis
Publicado: (2010)

Assessment of Loiasis and Outcomes of Ivermectin Masstreatment in Ijebu-North, Nigeria
por: Hassan, A. A., et al.
Publicado: (2011)

Onchocerciasis in the Ntui Health District of Cameroon: epidemiological, entomological and parasitological findings in relation to elimination prospects
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2022)

Individual risk of post-ivermectin serious adverse events in subjects infected with Loa loa
por: Chesnais, Cédric B., et al.
Publicado: (2020)

Prevalence of onchocerciasis in the Fundong Health District, Cameroon after 6 years of continuous community-directed treatment with ivermectin
por: Kamga, Henri Lucien Fouamno, et al.
Publicado: (2011)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2018)

First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination
por: Nana-Djeunga, Hugues C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pgvrbekib1rks1obk8v3neeqle